SIMILAR PATTERNS OF AMINO ACIDS FOR 2O4L_A_TPVA403_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a6d THERMOSOME (BETA
SUBUNIT)


(Thermoplasma
acidophilum)
PF00118
(Cpn60_TCP1)
6 LEU B 449
ALA B 413
ILE B 503
GLY B 499
VAL B 498
ILE B 445
None
1.24A 2o4lB-1a6dB:
undetectable
2o4lB-1a6dB:
12.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ao0 GLUTAMINE
PHOSPHORIBOSYLPYROPH
OSPHATE
AMIDOTRANSFERASE


(Bacillus
subtilis)
PF00156
(Pribosyltran)
PF13522
(GATase_6)
6 GLY A  30
ALA A  31
ILE A  33
GLY A  69
VAL A   3
ILE A  50
None
1.21A 2o4lB-1ao0A:
0.0
2o4lB-1ao0A:
14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bou 4,5-DIOXYGENASE BETA
CHAIN


(Sphingomonas
paucimobilis)
PF02900
(LigB)
5 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.83A 2o4lB-1bouB:
undetectable
2o4lB-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 ASP E 215
GLY E 217
VAL E 222
GLY E  76
ILE E 300
None
0.54A 2o4lB-1cziE:
6.8
2o4lB-1cziE:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gpe PROTEIN (GLUCOSE
OXIDASE)


(Penicillium
amagasakiense)
PF00732
(GMC_oxred_N)
PF05199
(GMC_oxred_C)
6 LEU A  52
GLY A  31
ALA A  30
VAL A 289
GLY A 255
VAL A 283
None
FAD  A 600 (-3.2A)
FAD  A 600 ( 4.8A)
None
None
None
1.27A 2o4lB-1gpeA:
undetectable
2o4lB-1gpeA:
9.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gpm GMP SYNTHETASE

(Escherichia
coli)
PF00117
(GATase)
PF00958
(GMP_synt_C)
PF02540
(NAD_synthase)
5 LEU A 393
GLY A 237
VAL A 384
ILE A 337
GLY A 335
None
POP  A 526 (-3.4A)
None
None
None
0.89A 2o4lB-1gpmA:
undetectable
2o4lB-1gpmA:
11.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
VAL A  32
GLY A  48
VAL A  82
ILE A  84
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-4.1A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
1.04A 2o4lB-1hvcA:
14.0
2o4lB-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
A79  A 800 (-3.6A)
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 (-3.4A)
1.49A 2o4lB-1hvcA:
14.0
2o4lB-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
ILE A  84
A79  A 800 (-3.4A)
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.6A)
0.57A 2o4lB-1hvcA:
14.0
2o4lB-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
VAL A  82
ILE A  84
A79  A 800 (-3.6A)
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.53A 2o4lB-1hvcA:
14.0
2o4lB-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  50
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-3.6A)
1.29A 2o4lB-1hvcA:
14.0
2o4lB-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
VAL A  32
ILE A  50
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.3A)
A79  A 800 (-3.8A)
A79  A 800 (-3.8A)
1.27A 2o4lB-1hvcA:
14.0
2o4lB-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
VAL A  82
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.49A 2o4lB-1hvcA:
14.0
2o4lB-1hvcA:
48.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kcx DIHYDROPYRIMIDINASE
RELATED PROTEIN-1


(Mus musculus)
PF01979
(Amidohydro_1)
6 GLY A  46
ALA A  33
ASP A  34
VAL A  65
ILE A  19
ILE A  24
None
1.30A 2o4lB-1kcxA:
undetectable
2o4lB-1kcxA:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kcx DIHYDROPYRIMIDINASE
RELATED PROTEIN-1


(Mus musculus)
PF01979
(Amidohydro_1)
6 GLY A  46
ALA A  33
ASP A  34
VAL A  65
VAL A 403
ILE A  24
None
1.49A 2o4lB-1kcxA:
undetectable
2o4lB-1kcxA:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kht ADENYLATE KINASE

(Methanococcus
voltae)
PF13207
(AAA_17)
6 LEU A 117
ALA A 159
GLY A  10
VAL A 121
VAL A   6
ILE A 118
None
1.40A 2o4lB-1khtA:
undetectable
2o4lB-1khtA:
22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mf1 ADENYLOSUCCINATE
SYNTHETASE


(Mus musculus)
PF00709
(Adenylsucc_synt)
5 LEU A 406
ASP A 368
ILE A 366
VAL A 375
ILE A 373
None
0.85A 2o4lB-1mf1A:
undetectable
2o4lB-1mf1A:
11.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mq0 CYTIDINE DEAMINASE

(Homo sapiens)
PF00383
(dCMP_cyt_deam_1)
5 ALA A  70
GLY A  39
VAL A  38
VAL A 115
ILE A  85
None
None
BRD  A 148 (-4.2A)
None
None
0.89A 2o4lB-1mq0A:
undetectable
2o4lB-1mq0A:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p3w CYSTEINE DESULFURASE

(Escherichia
coli)
no annotation 6 LEU B  61
GLY B 204
ILE B 249
GLY B 251
VAL B  19
ILE B  58
None
1.27A 2o4lB-1p3wB:
undetectable
2o4lB-1p3wB:
14.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1prs DEVELOPMENT-SPECIFIC
PROTEIN S


(Myxococcus
xanthus)
PF00030
(Crystall)
5 LEU A  19
GLY A  22
VAL A  44
VAL A   6
ILE A   4
None
0.85A 2o4lB-1prsA:
undetectable
2o4lB-1prsA:
21.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  84
None
0.51A 2o4lB-1q9pA:
10.4
2o4lB-1q9pA:
94.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qah PERCHLORIC ACID
SOLUBLE PROTEIN


(Rattus
norvegicus)
PF01042
(Ribonuc_L-PSP)
6 GLY A  69
ALA A  68
VAL A  32
ILE A  64
GLY A  62
ILE A  30
None
1.30A 2o4lB-1qahA:
undetectable
2o4lB-1qahA:
23.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rgy BETA-LACTAMASE

(Citrobacter
freundii)
PF00144
(Beta-lactamase)
5 LEU A  62
ILE A 155
GLY A  71
VAL A  72
VAL A 223
None
0.88A 2o4lB-1rgyA:
undetectable
2o4lB-1rgyA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s6r BETA-LACTAMASE

(Enterobacter
cloacae)
PF00144
(Beta-lactamase)
5 LEU A  62
ILE A 155
GLY A  71
VAL A  72
VAL A 223
None
0.88A 2o4lB-1s6rA:
undetectable
2o4lB-1s6rA:
15.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
None
0.55A 2o4lB-1sivA:
18.3
2o4lB-1sivA:
49.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to3 PUTATIVE ALDOLASE
YIHT


(Salmonella
enterica)
PF01791
(DeoC)
6 LEU A 184
GLY A 188
ALA A 189
ASP A 190
VAL A 127
ILE A 158
None
0.86A 2o4lB-1to3A:
undetectable
2o4lB-1to3A:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u3t ALCOHOL
DEHYDROGENASE ALPHA
CHAIN


(Homo sapiens)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
6 LEU A 141
GLY A 173
VAL A 152
ILE A  38
VAL A  43
ILE A 143
CCB  A1378 ( 4.8A)
None
None
None
None
None
1.25A 2o4lB-1u3tA:
undetectable
2o4lB-1u3tA:
14.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uio ADENOSINE DEAMINASE

(Mus musculus)
PF00962
(A_deaminase)
5 LEU A 231
GLY A 203
ALA A 204
VAL A 165
VAL A 213
None
0.88A 2o4lB-1uioA:
undetectable
2o4lB-1uioA:
15.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vkn N-ACETYL-GAMMA-GLUTA
MYL-PHOSPHATE
REDUCTASE


(Thermotoga
maritima)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
5 LEU A  70
VAL A 139
ILE A 120
VAL A  89
ILE A  91
None
0.85A 2o4lB-1vknA:
undetectable
2o4lB-1vknA:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wdt ELONGATION FACTOR G
HOMOLOG


(Thermus
thermophilus)
PF00009
(GTP_EFTU)
PF00679
(EFG_C)
PF03764
(EFG_IV)
PF14492
(EFG_II)
5 ALA A 237
VAL A 213
GLY A 231
VAL A 208
ILE A 212
None
0.84A 2o4lB-1wdtA:
undetectable
2o4lB-1wdtA:
9.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wsv AMINOMETHYLTRANSFERA
SE


(Homo sapiens)
PF01571
(GCV_T)
PF08669
(GCV_T_C)
5 LEU A 152
VAL A 192
GLY A 166
VAL A 207
ILE A 205
LEU  A 152 ( 0.6A)
VAL  A 192 ( 0.6A)
GLY  A 166 ( 0.0A)
VAL  A 207 ( 0.6A)
ILE  A 205 ( 0.4A)
0.76A 2o4lB-1wsvA:
undetectable
2o4lB-1wsvA:
15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zo1 TRANSLATION
INITIATION FACTOR 1


(Escherichia
coli)
PF01176
(eIF-1a)
6 LEU W  26
GLY W  65
ALA W  34
VAL W  13
ILE W  47
VAL W  68
None
1.05A 2o4lB-1zo1W:
undetectable
2o4lB-1zo1W:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b4q RHAMNOLIPIDS
BIOSYNTHESIS
3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE


(Pseudomonas
aeruginosa)
PF13561
(adh_short_C2)
6 ARG A  85
GLY A 237
ALA A 236
VAL A  90
ILE A  25
ILE A  88
None
1.16A 2o4lB-2b4qA:
undetectable
2o4lB-2b4qA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bi7 UDP-GALACTOPYRANOSE
MUTASE


(Klebsiella
pneumoniae)
PF03275
(GLF)
PF13450
(NAD_binding_8)
5 GLY A  12
ALA A  11
VAL A 213
VAL A  29
ILE A  31
FAD  A1385 (-3.4A)
None
None
None
None
0.85A 2o4lB-2bi7A:
undetectable
2o4lB-2bi7A:
12.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bih NITRATE REDUCTASE
[NADPH]


(Ogataea angusta)
PF00174
(Oxidored_molyb)
PF03404
(Mo-co_dimer)
5 LEU A 256
GLY A 178
ALA A 180
VAL A 107
ILE A 109
None
0.87A 2o4lB-2bihA:
undetectable
2o4lB-2bihA:
11.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bii NITRATE REDUCTASE
[NADPH]


(Ogataea angusta)
PF00174
(Oxidored_molyb)
PF03404
(Mo-co_dimer)
5 LEU A 256
GLY A 178
ALA A 180
VAL A 107
ILE A 109
None
0.81A 2o4lB-2biiA:
undetectable
2o4lB-2biiA:
12.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bmy RIPENING-ASSOCIATED
PROTEIN


(Musa acuminata)
PF01419
(Jacalin)
6 LEU A  92
GLY A 126
ALA A 134
VAL A  80
GLY A   8
VAL A   7
None
1.42A 2o4lB-2bmyA:
undetectable
2o4lB-2bmyA:
23.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cun PHOSPHOGLYCERATE
KINASE


(Pyrococcus
horikoshii)
PF00162
(PGK)
5 LEU A 316
ILE A 376
GLY A 357
VAL A 343
ILE A 347
None
0.79A 2o4lB-2cunA:
undetectable
2o4lB-2cunA:
13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dpl GMP SYNTHASE
[GLUTAMINE-HYDROLYZI
NG] SUBUNIT B


(Pyrococcus
horikoshii)
PF00958
(GMP_synt_C)
PF02540
(NAD_synthase)
5 LEU A 178
GLY A  30
VAL A 169
ILE A 129
GLY A 127
None
0.87A 2o4lB-2dplA:
undetectable
2o4lB-2dplA:
16.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  53
GLY A  55
VAL A  56
VAL A  87
ILE A  89
LP1  A 201 (-3.5A)
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.7A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.68A 2o4lB-2fmbA:
14.9
2o4lB-2fmbA:
33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fr5 CYTIDINE DEAMINASE

(Mus musculus)
PF00383
(dCMP_cyt_deam_1)
5 ALA A  70
GLY A  39
VAL A  38
VAL A 115
ILE A  85
None
None
TYU  A1001 (-4.1A)
None
None
0.82A 2o4lB-2fr5A:
undetectable
2o4lB-2fr5A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fr5 CYTIDINE DEAMINASE

(Mus musculus)
PF00383
(dCMP_cyt_deam_1)
5 ARG A 103
GLY A  39
VAL A  38
VAL A 115
ILE A  85
None
None
TYU  A1001 (-4.1A)
None
None
0.88A 2o4lB-2fr5A:
undetectable
2o4lB-2fr5A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gh9 MALTOSE/MALTODEXTRIN
-BINDING PROTEIN


(Thermus
thermophilus)
PF13416
(SBP_bac_8)
5 GLY A  74
ALA A  73
GLY A  68
VAL A  67
ILE A  47
None
0.87A 2o4lB-2gh9A:
undetectable
2o4lB-2gh9A:
18.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h0i THIOL:DISULFIDE
INTERCHANGE PROTEIN
DSBG


(Escherichia
coli)
PF13098
(Thioredoxin_2)
5 GLY A  14
VAL A   7
ILE A  17
GLY A  32
ILE A  10
None
0.89A 2o4lB-2h0iA:
undetectable
2o4lB-2h0iA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hk7 SHIKIMATE
DEHYDROGENASE


(Aquifex
aeolicus)
PF01488
(Shikimate_DH)
PF08501
(Shikimate_dh_N)
6 GLY A 146
ALA A 147
VAL A 183
ILE A 118
VAL A 128
ILE A 126
None
1.00A 2o4lB-2hk7A:
undetectable
2o4lB-2hk7A:
17.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iht CARBOXYETHYLARGININE
SYNTHASE


(Streptomyces
clavuligerus)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
6 LEU A 239
VAL A 233
ILE A 228
GLY A 224
VAL A 343
ILE A 236
None
1.46A 2o4lB-2ihtA:
undetectable
2o4lB-2ihtA:
10.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iq1 PROTEIN PHOSPHATASE
2C KAPPA, PPM1K


(Homo sapiens)
PF00481
(PP2C)
6 LEU A 269
ASP A 266
GLY A 187
GLY A 207
VAL A 206
VAL A 254
None
1.47A 2o4lB-2iq1A:
undetectable
2o4lB-2iq1A:
18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iss PYRIDOXAL
BIOSYNTHESIS LYASE
PDXS


(Thermotoga
maritima)
PF01680
(SOR_SNZ)
5 LEU A 224
GLY A 229
ALA A 230
ASP A 231
VAL A 158
None
0.87A 2o4lB-2issA:
undetectable
2o4lB-2issA:
15.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ji9 OXALYL-COA
DECARBOXYLASE


(Oxalobacter
formigenes)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
6 LEU A 254
GLY A 221
ALA A 224
ILE A 305
VAL A 237
ILE A 233
None
ADP  A1556 (-3.3A)
None
None
None
None
1.43A 2o4lB-2ji9A:
undetectable
2o4lB-2ji9A:
11.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o14 HYPOTHETICAL PROTEIN
YXIM


(Bacillus
subtilis)
PF13472
(Lipase_GDSL_2)
6 GLY A 231
ASP A 271
ILE A 364
GLY A 366
VAL A 202
ILE A 165
None
1.49A 2o4lB-2o14A:
undetectable
2o4lB-2o14A:
14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o7q BIFUNCTIONAL
3-DEHYDROQUINATE
DEHYDRATASE/SHIKIMAT
E DEHYDROGENASE


(Arabidopsis
thaliana)
PF01487
(DHquinase_I)
PF01488
(Shikimate_DH)
PF08501
(Shikimate_dh_N)
5 GLY A 236
ALA A 237
ASP A 238
ILE A 210
ILE A 232
None
0.80A 2o4lB-2o7qA:
undetectable
2o4lB-2o7qA:
12.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q0l THIOREDOXIN
REDUCTASE


(Helicobacter
pylori)
PF07992
(Pyr_redox_2)
5 ALA A   5
VAL A  84
ILE A 108
GLY A   8
ILE A  93
None
None
None
FAD  A 400 (-3.2A)
None
0.84A 2o4lB-2q0lA:
undetectable
2o4lB-2q0lA:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q50 GLYOXYLATE
REDUCTASE/HYDROXYPYR
UVATE REDUCTASE


(Homo sapiens)
PF00389
(2-Hacid_dh)
PF02826
(2-Hacid_dh_C)
6 GLY A  72
ALA A  71
VAL A  63
ILE A  78
GLY A  54
ILE A  67
None
1.44A 2o4lB-2q50A:
undetectable
2o4lB-2q50A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qjg PUTATIVE ALDOLASE
MJ0400


(Methanocaldococcus
jannaschii)
PF01791
(DeoC)
5 LEU A 174
GLY A 179
ALA A 180
ASP A 181
ILE A 149
None
0.71A 2o4lB-2qjgA:
undetectable
2o4lB-2qjgA:
14.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qxl HEAT SHOCK PROTEIN
HOMOLOG SSE1


(Saccharomyces
cerevisiae)
PF00012
(HSP70)
6 ARG A  20
GLY A 375
ALA A 376
VAL A 141
ILE A 143
VAL A  15
None
1.08A 2o4lB-2qxlA:
undetectable
2o4lB-2qxlA:
9.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qy1 PECTATE LYASE II

(Xanthomonas
campestris)
PF00544
(Pec_lyase_C)
5 GLY A 110
VAL A 154
ILE A 178
VAL A 120
ILE A 122
None
0.90A 2o4lB-2qy1A:
undetectable
2o4lB-2qy1A:
14.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ri6 2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE


(Paraburkholderia
xenovorans)
PF12697
(Abhydrolase_6)
7 LEU A 283
GLY A  63
ALA A  62
GLY A  57
VAL A  56
VAL A 279
ILE A 280
None
1.05A 2o4lB-2ri6A:
undetectable
2o4lB-2ri6A:
16.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
AB1  A 501 ( 4.7A)
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
1.49A 2o4lB-2rkfA:
20.4
2o4lB-2rkfA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
AB1  A 501 ( 4.7A)
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 4.2A)
0.44A 2o4lB-2rkfA:
20.4
2o4lB-2rkfA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
7 ARG A  10
LEU A  35
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
0.78A 2o4lB-2rspA:
12.9
2o4lB-2rspA:
32.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
7 ARG A 105
LEU A  35
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
1.50A 2o4lB-2rspA:
12.9
2o4lB-2rspA:
32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vge RELA-ASSOCIATED
INHIBITOR


(Homo sapiens)
PF00023
(Ank)
PF14604
(SH3_9)
6 LEU A 640
ALA A 635
VAL A 676
ILE A 668
GLY A 670
ILE A 675
None
1.45A 2o4lB-2vgeA:
undetectable
2o4lB-2vgeA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vr5 GLYCOGEN OPERON
PROTEIN GLGX


(Sulfolobus
solfataricus)
PF00128
(Alpha-amylase)
PF02806
(Alpha-amylase_C)
PF02922
(CBM_48)
5 LEU A 211
GLY A 280
ALA A 279
VAL A 273
ILE A 208
None
0.80A 2o4lB-2vr5A:
undetectable
2o4lB-2vr5A:
9.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vvg KINESIN-2

(Giardia
intestinalis)
PF00225
(Kinesin)
5 LEU A 307
ASP A 241
ILE A 117
GLY A 115
ILE A  93
None
MG  A1352 ( 4.1A)
None
None
None
0.88A 2o4lB-2vvgA:
undetectable
2o4lB-2vvgA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wt9 NICOTINAMIDASE

(Acinetobacter
baumannii)
PF00857
(Isochorismatase)
5 ALA A  32
ASP A  33
VAL A  17
ILE A  36
ILE A 154
None
0.88A 2o4lB-2wt9A:
undetectable
2o4lB-2wt9A:
17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yb6 UBIQUITIN-CONJUGATIN
G ENZYME E2 B


(Homo sapiens)
PF00179
(UQ_con)
5 GLY A  26
ALA A  38
VAL A  70
ILE A 109
ILE A  57
None
0.81A 2o4lB-2yb6A:
undetectable
2o4lB-2yb6A:
19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z0j PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA1438


(Thermus
thermophilus)
PF04029
(2-ph_phosp)
6 ARG A 129
GLY A 156
ALA A 155
GLY A 173
VAL A 136
ILE A 138
None
1.20A 2o4lB-2z0jA:
undetectable
2o4lB-2z0jA:
17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zj9 AMPC

(Escherichia
coli)
PF00144
(Beta-lactamase)
5 LEU A  62
ILE A 155
GLY A  71
VAL A  72
VAL A 223
None
0.86A 2o4lB-2zj9A:
undetectable
2o4lB-2zj9A:
14.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zz8 LIPL32 PROTEIN

(Leptospira
interrogans)
PF12103
(Lipl32)
5 LEU A  63
VAL A 118
ILE A 165
GLY A  75
ILE A 193
None
0.88A 2o4lB-2zz8A:
undetectable
2o4lB-2zz8A:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqc COMPONENT A OF
HEXAPRENYL
DIPHOSPHATE SYNTHASE


(Micrococcus
luteus)
no annotation 6 LEU A  95
ASP A  27
VAL A  48
ILE A  31
VAL A  43
ILE A  47
None
1.35A 2o4lB-3aqcA:
undetectable
2o4lB-3aqcA:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c4n UNCHARACTERIZED
PROTEIN DR_0571


(Deinococcus
radiodurans)
PF01266
(DAO)
5 LEU A 370
GLY A 200
VAL A  40
VAL A 230
ILE A 228
None
0.80A 2o4lB-3c4nA:
undetectable
2o4lB-3c4nA:
12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d79 PUTATIVE
UNCHARACTERIZED
PROTEIN PH0734


(Pyrococcus
horikoshii)
PF01472
(PUA)
PF09183
(DUF1947)
6 LEU A 101
GLY A  95
ALA A  96
VAL A 106
ILE A 111
ILE A 100
None
1.06A 2o4lB-3d79A:
undetectable
2o4lB-3d79A:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dmo CYTIDINE DEAMINASE

(Burkholderia
pseudomallei)
PF00383
(dCMP_cyt_deam_1)
5 ALA A  58
GLY A  27
VAL A  26
VAL A 105
ILE A  75
None
0.89A 2o4lB-3dmoA:
undetectable
2o4lB-3dmoA:
24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eb2 PUTATIVE
DIHYDRODIPICOLINATE
SYNTHETASE


(Rhodopseudomonas
palustris)
PF00701
(DHDPS)
5 GLY A 181
ILE A 200
GLY A 202
VAL A 203
ILE A 176
None
0.88A 2o4lB-3eb2A:
undetectable
2o4lB-3eb2A:
15.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eg4 2,3,4,5-TETRAHYDROPY
RIDINE-2,6-DICARBOXY
LATE
N-SUCCINYLTRANSFERAS
E


(Brucella suis)
PF00132
(Hexapep)
PF14602
(Hexapep_2)
PF14805
(THDPS_N_2)
6 LEU A 130
GLY A 144
ALA A 145
ILE A 185
VAL A 135
ILE A 147
None
1.35A 2o4lB-3eg4A:
undetectable
2o4lB-3eg4A:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3emk GLUCOSE/RIBITOL
DEHYDROGENASE


(Brucella
melitensis)
PF13561
(adh_short_C2)
6 LEU A 118
GLY A  13
ALA A  88
VAL A 110
ILE A  90
VAL A  67
None
1.48A 2o4lB-3emkA:
undetectable
2o4lB-3emkA:
18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eya PYRUVATE
DEHYDROGENASE
[CYTOCHROME]


(Escherichia
coli)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
6 LEU A  85
GLY A  72
ALA A  71
VAL A  69
VAL A 158
VAL A 154
None
1.30A 2o4lB-3eyaA:
undetectable
2o4lB-3eyaA:
12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fbs OXIDOREDUCTASE

(Agrobacterium
fabrum)
PF07992
(Pyr_redox_2)
5 GLY A 284
ALA A  17
ILE A  66
GLY A  22
ILE A   7
None
0.86A 2o4lB-3fbsA:
undetectable
2o4lB-3fbsA:
15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf7 GLUTACONYL-COA
DECARBOXYLASE
SUBUNIT A


([Clostridium]
symbiosum)
PF01039
(Carboxyl_trans)
5 LEU A 148
GLY A 191
ALA A 213
GLY A 256
ILE A 189
None
0.89A 2o4lB-3gf7A:
undetectable
2o4lB-3gf7A:
11.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gh8 IODOTYROSINE
DEHALOGENASE 1


(Mus musculus)
PF00881
(Nitroreductase)
5 LEU A 256
GLY A 218
ILE A 116
GLY A 120
ILE A 190
None
0.84A 2o4lB-3gh8A:
undetectable
2o4lB-3gh8A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gt7 SENSOR PROTEIN

(Syntrophus
aciditrophicus)
PF00072
(Response_reg)
6 ARG A 102
GLY A 107
ALA A 108
ASP A 109
ILE A  59
VAL A  63
None
1.19A 2o4lB-3gt7A:
undetectable
2o4lB-3gt7A:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gvc PROBABLE SHORT-CHAIN
TYPE
DEHYDROGENASE/REDUCT
ASE


(Mycobacterium
tuberculosis)
PF13561
(adh_short_C2)
5 GLY A 137
ALA A 138
GLY A 112
VAL A 113
ILE A 182
None
0.86A 2o4lB-3gvcA:
undetectable
2o4lB-3gvcA:
16.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hdy UDP-GALACTOPYRANOSE
MUTASE


(Deinococcus
radiodurans)
PF03275
(GLF)
PF13450
(NAD_binding_8)
5 GLY A  38
ALA A  37
VAL A 237
VAL A  55
ILE A  57
FAD  A 450 (-3.3A)
None
None
None
None
0.77A 2o4lB-3hdyA:
undetectable
2o4lB-3hdyA:
12.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hh1 TETRAPYRROLE
METHYLASE FAMILY
PROTEIN


(Chlorobaculum
tepidum)
PF00590
(TP_methylase)
5 LEU A  79
GLY A 111
ALA A 110
VAL A  75
ILE A  76
None
0.83A 2o4lB-3hh1A:
undetectable
2o4lB-3hh1A:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i3o SHORT CHAIN
DEHYDROGENASE


(Bacillus
anthracis)
PF13561
(adh_short_C2)
6 GLY A 101
ILE A  73
GLY A  51
VAL A 130
VAL A 113
ILE A 112
None
None
NAE  A 311 (-3.5A)
NAE  A 311 (-3.5A)
None
None
1.47A 2o4lB-3i3oA:
undetectable
2o4lB-3i3oA:
18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i4o TRANSLATION
INITIATION FACTOR
IF-1


(Mycobacterium
tuberculosis)
PF01176
(eIF-1a)
6 LEU A  27
GLY A  66
ALA A  35
VAL A  14
ILE A  48
ILE A  25
None
1.08A 2o4lB-3i4oA:
undetectable
2o4lB-3i4oA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j7a 40S RIBOSOMAL
PROTEIN ES6


(Plasmodium
falciparum)
PF01092
(Ribosomal_S6e)
5 LEU H 111
GLY H  55
ILE H 101
GLY H 103
ILE H  52
None
G  A 160 ( 3.9A)
None
None
None
0.78A 2o4lB-3j7aH:
undetectable
2o4lB-3j7aH:
16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jv7 ADH-A

(Rhodococcus
ruber)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 211
GLY A 216
ALA A 217
ASP A 218
ILE A 200
None
0.86A 2o4lB-3jv7A:
undetectable
2o4lB-3jv7A:
12.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ka7 OXIDOREDUCTASE

(Methanosarcina
mazei)
PF01593
(Amino_oxidase)
6 GLY A  63
ALA A  66
VAL A  76
ILE A 198
VAL A  79
ILE A  78
None
1.38A 2o4lB-3ka7A:
undetectable
2o4lB-3ka7A:
16.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kiz PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
CYCLO-LIGASE


(Cytophaga
hutchinsonii)
PF02769
(AIRS_C)
5 GLY A  59
ASP A 161
ILE A 108
VAL A  77
ILE A  81
EDO  A 398 ( 3.8A)
None
ACT  A 394 ( 4.6A)
None
None
0.81A 2o4lB-3kizA:
undetectable
2o4lB-3kizA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3krz NADH:FLAVIN
OXIDOREDUCTASE/NADH
OXIDASE


(Thermoanaerobacter
pseudethanolicus)
PF00724
(Oxidored_FMN)
5 LEU A 101
VAL A 215
ILE A 239
VAL A 160
ILE A 162
None
0.86A 2o4lB-3krzA:
undetectable
2o4lB-3krzA:
13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lkb PROBABLE
BRANCHED-CHAIN AMINO
ACID ABC
TRANSPORTER, AMINO
ACID BINDING PROTEIN


(Thermus
thermophilus)
PF13458
(Peripla_BP_6)
5 ALA A 167
VAL A 146
ILE A 137
VAL A 177
ILE A 174
None
0.79A 2o4lB-3lkbA:
undetectable
2o4lB-3lkbA:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lm2 PUTATIVE KINASE

(Agrobacterium
fabrum)
PF00480
(ROK)
6 LEU A 114
GLY A 123
ALA A 100
ASP A  99
GLY A 189
VAL A 185
None
EDO  A 227 ( 4.8A)
EDO  A 227 (-3.9A)
EDO  A 227 (-4.3A)
EDO  A 227 (-3.1A)
None
1.42A 2o4lB-3lm2A:
undetectable
2o4lB-3lm2A:
16.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lun ULILYSIN

(Methanosarcina
acetivorans)
PF05572
(Peptidase_M43)
6 ALA A 209
VAL A 175
ILE A  82
GLY A 211
VAL A 203
ILE A 205
None
1.35A 2o4lB-3lunA:
undetectable
2o4lB-3lunA:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdo PUTATIVE
PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
CYCLO-LIGASE


(Parabacteroides
distasonis)
PF02769
(AIRS_C)
5 GLY A  58
ASP A 160
ILE A 107
VAL A  76
ILE A  80
None
None
ACT  A 395 (-4.3A)
None
None
0.82A 2o4lB-3mdoA:
undetectable
2o4lB-3mdoA:
15.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  32
ILE A  47
GLY A  49
VAL A  82
ILE A  84
None
0.52A 2o4lB-3mwsA:
19.4
2o4lB-3mwsA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8l 6-PHOSPHOFRUCTOKINAS
E, MUSCLE TYPE


(Oryctolagus
cuniculus)
PF00365
(PFK)
5 GLY A 224
ALA A 225
ASP A 226
VAL A 207
ILE A 261
PO4  A 767 ( 4.6A)
None
None
None
None
0.87A 2o4lB-3o8lA:
undetectable
2o4lB-3o8lA:
8.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ogz UDP-SUGAR
PYROPHOSPHORYLASE


(Leishmania
major)
PF01704
(UDPGP)
6 GLY A 122
ALA A 121
ASP A 271
ILE A 269
VAL A 227
ILE A 167
None
1.29A 2o4lB-3ogzA:
undetectable
2o4lB-3ogzA:
10.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3opy 6-PHOSPHOFRUCTO-1-KI
NASE ALPHA-SUBUNIT


(Komagataella
pastoris)
PF00365
(PFK)
5 GLY A 419
ALA A 420
ASP A 421
VAL A 402
ILE A 457
None
0.82A 2o4lB-3opyA:
undetectable
2o4lB-3opyA:
8.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ouk PROBABLE CONSERVED
TRANSMEMBRANE
PROTEIN


(Mycobacterium
tuberculosis)
no annotation 5 LEU A  81
GLY A 145
ALA A 144
VAL A  89
ILE A  84
None
0.89A 2o4lB-3oukA:
undetectable
2o4lB-3oukA:
19.77